Skip to main content
. 2016 Aug 1;8(56):95054–95065. doi: 10.18632/oncotarget.10982

Figure 5. Association between seven-gene signature and OS in patients with stage II and III CRC.

Figure 5

(A) For 382 CRC patients from TCGA, Stage III tumors were associated with greater 5-year mortality than stage II tumors. (B) 382 CRC patients were divided into high and low risk group based on their survival risk scores. The association between seven-gene signature (risk scores) and 5-year OS in patients with stage II and III CRC was assessed simultaneously (panel B) or individually (stage II in panel (C); stage III in panel (D) by Kaplan–Meier curves.